Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Human oligodendrocytes in remyelination research.
A Swiss real world best practice experience in three different clinical settings of the 6 hour fingolimod first dose observation procedure.
HLA associations in South Asian multiple sclerosis.
Identifying the biomarkers of multiple sclerosis based on non-coding RNA signature.
Association between a Functional HLA-G 14-bp Insertion/deletion Polymorphism and Susceptibility to Autoimmune Diseases: A Meta-analysis.
Efficacy and Safety of Fingolimod in an Unselected Patient Population.
Visualisation of the medial longitudinal fasciculus using fibre tractography in multiple sclerosis patients with internuclear ophthalmoplegia.
Glutamate signaling in benign and malignant disorders: current status, future perspectives, and therapeutic implications.
Autoantigens and autoantibodies in multiple sclerosis.
Ribosomal protein S6 mRNA is a biomarker upregulated in multiple sclerosis, downregulated by interferon treatment, and affected by season.
Goodbye to all that: a short history of CCSVI.
[New and future treatments for neurological disorders--knowledge essential to daily clinics and future prospects. Topics: 8. Guillain-Barré syndrome and chronic inflammatory demyelinating polyneuropathy].
Interactions of environment and genes in multiple sclerosis.
Implementation of the 'Sapere Migliora' information aid for newly diagnosed people with multiple sclerosis in routine clinical practice: a late-phase controlled trial.
Evaluation of the implication of KIR2DL2 receptor in multiple sclerosis and herpesvirus susceptibility.
Neuroinflammation. Contemporary anti-inflammatory treatment approaches.
Claudin Proteins And Neuronal Function.
The Olig family affects central nervous system development and disease.
[A review of multiple sclerosis (1). Presentation of a case.]
Ulcerative Colitis and Perfluorooctanoic Acid (PFOA) in a Highly Exposed Population of Community Residents and Workers in the Mid-Ohio Valley.
Postural control strategy during standing is altered in patients with multiple sclerosis.
Cerebrospinal fluid oligoclonal IgG bands in multiple sclerosis: what does it mean?
Use of the 2010 McDonald Criteria Can Facilitate Early Diagnosis of Pediatric Multiple Sclerosis in a Predominantly Black Cohort.
Two Multiple Sclerosis Quality-of-Life Measures: Comparison in a National Sample.
Persistence and pathogenesis of the neurotropic polyomavirus JC.
Pages
« first
‹ previous
…
444
445
446
447
448
449
450
451
452
…
next ›
last »